Matches in Wikidata for { <http://www.wikidata.org/entity/Q53658745> ?p ?o ?g. }
- Q53658745 description "2014 nî lūn-bûn" @default.
- Q53658745 description "2014年の論文" @default.
- Q53658745 description "2014年学术文章" @default.
- Q53658745 description "2014年学术文章" @default.
- Q53658745 description "2014年学术文章" @default.
- Q53658745 description "2014年学术文章" @default.
- Q53658745 description "2014年学术文章" @default.
- Q53658745 description "2014年学术文章" @default.
- Q53658745 description "2014年學術文章" @default.
- Q53658745 description "2014年學術文章" @default.
- Q53658745 description "2014年學術文章" @default.
- Q53658745 description "2014年學術文章" @default.
- Q53658745 description "2014年學術文章" @default.
- Q53658745 description "2014년 논문" @default.
- Q53658745 description "article científic" @default.
- Q53658745 description "article scientific" @default.
- Q53658745 description "article scientifique" @default.
- Q53658745 description "articol științific" @default.
- Q53658745 description "articolo scientifico" @default.
- Q53658745 description "artigo científico" @default.
- Q53658745 description "artigo científico" @default.
- Q53658745 description "artigo científico" @default.
- Q53658745 description "artikel ilmiah" @default.
- Q53658745 description "artikull shkencor" @default.
- Q53658745 description "artikulong pang-agham" @default.
- Q53658745 description "artykuł naukowy" @default.
- Q53658745 description "artículo científico publicado en 2014" @default.
- Q53658745 description "artículu científicu" @default.
- Q53658745 description "bilimsel makale" @default.
- Q53658745 description "bài báo khoa học" @default.
- Q53658745 description "naučni članak" @default.
- Q53658745 description "scienca artikolo" @default.
- Q53658745 description "scientific article published on 27 December 2014" @default.
- Q53658745 description "scientific article published on 27 December 2014" @default.
- Q53658745 description "scientific article published on 27 December 2014" @default.
- Q53658745 description "teaduslik artikkel" @default.
- Q53658745 description "tieteellinen artikkeli" @default.
- Q53658745 description "tudományos cikk" @default.
- Q53658745 description "vedecký článok" @default.
- Q53658745 description "vetenskaplig artikel" @default.
- Q53658745 description "videnskabelig artikel" @default.
- Q53658745 description "vitenskapelig artikkel" @default.
- Q53658745 description "vitskapeleg artikkel" @default.
- Q53658745 description "vědecký článek" @default.
- Q53658745 description "wetenschappelijk artikel" @default.
- Q53658745 description "wissenschaftlicher Artikel" @default.
- Q53658745 description "επιστημονικό άρθρο" @default.
- Q53658745 description "мақолаи илмӣ" @default.
- Q53658745 description "наукова стаття, опублікована в грудні 2014" @default.
- Q53658745 description "научна статия" @default.
- Q53658745 description "научная статья" @default.
- Q53658745 description "научни чланак" @default.
- Q53658745 description "научни чланак" @default.
- Q53658745 description "מאמר מדעי" @default.
- Q53658745 description "مقالة علمية نشرت في 27 ديسمبر 2014" @default.
- Q53658745 description "২৭ ডিসেম্বর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q53658745 description "บทความทางวิทยาศาสตร์" @default.
- Q53658745 description "სამეცნიერო სტატია" @default.
- Q53658745 name "Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study." @default.
- Q53658745 name "Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study." @default.
- Q53658745 type Item @default.
- Q53658745 label "Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study." @default.
- Q53658745 label "Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study." @default.
- Q53658745 prefLabel "Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study." @default.
- Q53658745 prefLabel "Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study." @default.
- Q53658745 P1433 Q53658745-C5CB6E49-4C01-41D6-BD8B-84DD8C6C72B9 @default.
- Q53658745 P1476 Q53658745-B27C4DCC-9B3F-4BF4-86CA-49E3DE360C59 @default.
- Q53658745 P2093 Q53658745-43B9431C-2CBF-44DB-BBB5-BE586FEAA7F2 @default.
- Q53658745 P2093 Q53658745-46D8A70F-50FD-4582-847E-68AB4EF3E788 @default.
- Q53658745 P2093 Q53658745-4C238C19-6E08-4635-A2AF-F0A98DFC8B31 @default.
- Q53658745 P2093 Q53658745-6E28015D-2147-4EB9-B987-04EA9FAAEC17 @default.
- Q53658745 P2093 Q53658745-7C29E738-5E6D-4121-A122-285440839164 @default.
- Q53658745 P2093 Q53658745-941BDA79-8502-4438-933B-36C5757AF8F5 @default.
- Q53658745 P2093 Q53658745-9E1164F4-90B4-4BB5-99F3-7A82909A4AAD @default.
- Q53658745 P2093 Q53658745-9F8EB2BE-3258-49AB-BBF9-91767682DC60 @default.
- Q53658745 P2093 Q53658745-AB9652B5-DDC0-4C03-B8BA-5BF231E82850 @default.
- Q53658745 P2093 Q53658745-DFC0FC4E-D2B5-4473-BBDF-B9B4C93604BF @default.
- Q53658745 P2093 Q53658745-E707A34A-ED44-494F-9E5C-EE26DCA20EC9 @default.
- Q53658745 P2093 Q53658745-EF2D9D3D-EE65-4247-96D2-1225FE7CC017 @default.
- Q53658745 P2093 Q53658745-EFB8B7F2-0E97-4D0D-8C18-4CB44F9F8FA1 @default.
- Q53658745 P2093 Q53658745-F244C5A9-6C19-4AF5-98FF-2D9037745FF2 @default.
- Q53658745 P2093 Q53658745-F320D2DE-FBC8-42A8-B5BC-1F08DA6A8C68 @default.
- Q53658745 P2093 Q53658745-F5DB0A75-A655-4207-8D88-ADB5BC97765C @default.
- Q53658745 P2093 Q53658745-FCA83FD6-AFBB-4A20-BC9E-92907482CF81 @default.
- Q53658745 P2860 Q53658745-0B336979-B290-40D2-8E68-610CCF03F312 @default.
- Q53658745 P2860 Q53658745-1179610F-A6C1-43EF-8118-813C6930AB66 @default.
- Q53658745 P2860 Q53658745-242E2063-0A4E-4A53-AC23-74D37A80521F @default.
- Q53658745 P2860 Q53658745-37246F11-12DA-409D-93EB-5BB970401612 @default.
- Q53658745 P2860 Q53658745-414480E7-CAC7-4ACC-879B-B73F575BB7BC @default.
- Q53658745 P2860 Q53658745-55C94942-3672-4577-B4E1-BD3562CFA4E4 @default.
- Q53658745 P2860 Q53658745-83D4760F-1611-4289-8363-4F4CC5034BA6 @default.
- Q53658745 P2860 Q53658745-90A131E9-5747-4073-9FFA-CF4C78B0345B @default.
- Q53658745 P2860 Q53658745-B16939FB-4ECB-470C-A938-43E5D6A99E42 @default.
- Q53658745 P2860 Q53658745-B541CE25-83D6-4F87-A11B-5A78FC0E1388 @default.
- Q53658745 P2860 Q53658745-D3F0AB7D-A0FE-4A91-AAB2-2788B81C4BD5 @default.
- Q53658745 P2860 Q53658745-E4265BD0-A7E1-48AE-BA3A-A4968E219C83 @default.
- Q53658745 P2860 Q53658745-F83A682B-8050-428A-A4E7-B2E64FD44871 @default.
- Q53658745 P2888 Q53658745-CCFE4455-B283-4F21-A94C-EF10312216F8 @default.
- Q53658745 P304 Q53658745-0D0A6798-E6C6-4CEA-ADD2-4F98AC4C1963 @default.
- Q53658745 P31 Q53658745-D269A1E1-F81F-4826-8055-C25FAC109157 @default.